# OnCo record nct06239194 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06239194/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06239194", "NCT06239194" ;
  schema:name "Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors"@en ;
  schema:description "A phase 1/2 trial of MDX2001 in biliary tract cancer, cervical cancer, colorectal cancer, endometrial cancer, oesophageal cancer and gastric & gastro-oesophageal junction cancer, run by ModeX Therapeutics, An OPKO Health Company, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06239194/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06239194> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2024-06-12" ;
  onco:cancers <https://onco.cc/cancers/cholangiocarcinoma/>, <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/endometrial/>, <https://onco.cc/cancers/esophageal/>, <https://onco.cc/cancers/gastric/> ;
  onco:companies <https://onco.cc/companies/modex-therapeutics/> .